Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVI Dose-Ranging Study for Cervical Ripening and Labor Induction
NCT00828711Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Apr 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of misoprostol in cervical ripening (CR), induction of labor, sponsored by Ferring Pharmaceuticals. Started Apr 2009; status: completed.
02
Drugs
misoprostol
03
Conditions
cervical ripening (CR)induction of labor
Beyond the preview
Go deeper on NCT00828711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828711.